ONCOLYTICS BIOTECH INC (ONCY) has 12 open-market insider trades by 10 insiders since 2026. The most active filer is Bernd R. Seizinger, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Bernd R. Seizinger | Dir | — | 2 | $188K | 2026-02-12 |
| Jared Kelly | CEO | — | 2 | $34K | 2026-03-12 |
| Patricia S. Andrews | Dir | — | 1 | $30K | 2026-02-12 |
| Andrew Aromando | Chief Business Officer | — | 1 | $25K | 2026-02-11 |
| Wayne Pisano | Dir | — | 1 | $25K | 2026-02-12 |
| Deborah Margaret Brown | Dir | — | 1 | $21K | 2026-02-12 |
| James T. Parsons | Dir | — | 1 | $10K | 2026-03-11 |
| Kirk Look | CFO | — | 1 | $10K | 2026-02-12 |
| Thomas Charles Heineman | Chief Medical Officer | — | 1 | $10K | 2026-02-12 |
| Allison Hagerman | VPProduct Development | — | 1 | $8K | 2026-02-12 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Jared Kelly | CEO | Buy | $5K | 2026-03-12 |
| James T. Parsons | Director | Buy | $10K | 2026-03-11 |
| Allison Hagerman | VP & Product Development | Buy | $8K | 2026-02-12 |
| Wayne Pisano | Director | Buy | $25K | 2026-02-12 |
| Kirk Look | CFO | Buy | $10K | 2026-02-12 |
| Thomas Charles Heineman | Chief Medical Officer | Buy | $10K | 2026-02-12 |
Companies that share insiders with ONCY, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Deborah Margaret Brown | Director | Buy | $21K | 2026-02-12 |
| Patricia S. Andrews | Director | Buy | $30K | 2026-02-12 |
| Bernd R. Seizinger | Director | Buy | $84K | 2026-02-11 |
| Jared Kelly | CEO | Buy | $29K | 2026-02-11 |
| Andrew Aromando | Chief Business Officer | Buy | $25K | 2026-02-11 |
| Bernd R. Seizinger | Director | Buy | $104K | 2026-01-16 |